Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-06

Clinical Trial Update: Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection [Phase 3]

View source ↗

Summary

Phase 3 trial results for ММН-407 in acute viral respiratory infection have been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ММН-407

Snippet

Sponsor: Materia Medica Holding | Conditions: Viral Respiratory Infection | Phase 3 | Status: COMPLETED | Results posted: 2021-10-06